Top Markets
Coin of the day
InDex Pharmaceuticals Holding AB (publ) InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ)

INDEX
주식 순위 #28996
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to... InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
주가
$0.04406501
마지막 동기화: 2024-07-09
시가총액
$23.47M
변동 (1일)
-0.48%
변동 (1년)
0.00%
국가
SE
거래 InDex Pharmaceuticals Holding AB (publ) (INDEX)

카테고리

InDex Pharmaceuticals Holding AB (publ) (INDEX)의 주가 이력
최고 종가: $0.04 (2024-07-01 기준)

최저 종가: $0.27 (2016-10-01 기준)
InDex Pharmaceuticals Holding AB (publ)의 주가 이력 (2016 ~ 2026)
연간 주가 성과
연도 성과
2024 87.14%
2023 -26.23%
2022 -50.30%
2021 -15.30%
2020 -67.25%
2019 -14.75%
2018 30.01%
2017 -11.67%
2016 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH